Professional Documents
Culture Documents
Ncov - Resti 2-1-20 FIX PDF
Ncov - Resti 2-1-20 FIX PDF
Resti Yudhawati
INFLUENZA PANDEMI
SARS-CoV, MERS-CoV,
2019-nCoV
,
Cahscient.fies.eordpress.com/2008/textbook-mikrobologi15.doc 3
Orthomyxoviridae Coronaviridae
- Ada 3 stubtipe (influenza A, B, C) Virus 229E, OC43, NL63, HKU1 menyebabkan gejala
URI relatif ringan
Pandemik: Epidemik
influenza A: 2002 – 2003
1918 (H1N1) Novel coronavirus
Flu Spanyol , 100 juta kematian disebut:
1957 (H2N2) SARS-CoV 8422 kasus, 912 kematian
Asian flu, 2 juta kematian 2012-2013
1968 (H3N2) Novel coronavirus,
Hongkong flu, 500 ribu kematian Semenanjung. Arab:
2003 (H5N1) MERS-CoV 2494 kasus, 858 Kematian
China (Avian Influenza), 345 fatal Kematian 2019 -
H1N1 pdm 2009 2019-nCoV (Wuhan CoV)
USA , 12,469 Kematian 6065 kasus, 132 kematian
• Order: Nidovirales
• Family: Coronaviridae
• Genus: Alphacoronavirus, Betacoronavirus,
Gamacoronavirus, Deltacoronavirus
• ssRNA positive-strand virus
• Mammals ( humans, bats, cows, pigs)
Coronaviruses • Birds, chickens
Zoonosis
Alpha coronavirus
• Type Species : Human coronavirus 229 E, miniopterus Bat
coronavirus HKUB
Beta coronavirus
• Type Species : SARS CoV, MERS CoV, Human coronavirus
OC43, Wuhan coronavirus (2019-nCoV)
Gama coronavirua
• Type species: Avian corona virus, duck coronavirus
Delta coronavirus
• Type species: Bulbul coronavirusHKU11, Munia coronavirus
Classification of human coronavirus.
Alphacoronavirus Betacoronavirus
Positive SS RNA
26-32 KB
Animal origins of human coronaviruses
16
Jia
,
Mortality rates of 10% for SARS-CoV and 37% for MERS-CoV
Cui,2019
Human Transmission
• Preliminary analyses indicate that 2019- nCoV has some amino acid
homology to SARS-CoV and may be able to use ACE2 as a
receptor.
Paules et al, 2020
Phylogenetic Analysis of 2019-nCoV and Other Betacoronavirus
Genomes in the Orthocoronavirinae Subfamily
Rhinolophus sinicus
Zhu N, 2020
2019-nCoV
Zhu N, 2020
How dose 2019-nCoV spread
Huanan seafood
Market
Ongoing investigations
CDC, 2020
Incubation period
WHO, 2020
Management
• No specific treatment
• Focused on alleviation of symptoms.
• Anti viral are being studied
• So far, the fatality rate of 2019-nCoV is lower than
that of SARS-CoV and MERS-CoV; however, the
ultimate scope and effects of the outbreak remain to
be seen.
CDC, 2020